Youngy Health Co., Ltd. (SHE:300247)
4.080
-0.130 (-3.09%)
Jun 11, 2026, 11:00 AM CST
Youngy Health Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 67.55 | 74.8 | 46.85 | 26.58 | 126.31 | 24.2 |
Depreciation & Amortization | 27.47 | 27.47 | 28.69 | 27.98 | 28.39 | 22.61 |
Other Amortization | 0.37 | 0.37 | 0.24 | 0.26 | 0.19 | 0.24 |
Loss (Gain) From Sale of Assets | 0.1 | 0.1 | -0.01 | 0.5 | -0.59 | -0.03 |
Asset Writedown & Restructuring Costs | 9.72 | 9.72 | 8.65 | 0.38 | 1.7 | -0.02 |
Loss (Gain) From Sale of Investments | -11.73 | -11.73 | -16.25 | -17.28 | -137.89 | -19.86 |
Provision & Write-off of Bad Debts | 0.66 | 0.66 | 1.57 | 0.06 | 0.9 | -9.01 |
Other Operating Activities | 19.45 | 46.32 | 20.12 | 22.24 | 9.66 | 11.77 |
Change in Accounts Receivable | -21.08 | -21.08 | -37.39 | -2.49 | -14.68 | 15.87 |
Change in Inventory | -28.45 | -28.45 | -37.47 | 35.1 | -39.97 | -44.02 |
Change in Accounts Payable | 20.29 | 20.29 | 32.82 | -4.2 | -3.93 | 7.37 |
Change in Other Net Operating Assets | - | - | - | - | -6.02 | -0.16 |
Operating Cash Flow | 81.59 | 115.72 | 51.06 | 88.41 | -29.23 | 10.82 |
Operating Cash Flow Growth | 21.24% | 126.64% | -42.25% | - | - | -86.63% |
Capital Expenditures | -14.33 | -9.87 | -8.85 | -7.88 | -17.49 | -6.22 |
Sale of Property, Plant & Equipment | 0.22 | 0.21 | 0.14 | 0.53 | 1.19 | 0.17 |
Investment in Securities | 34.45 | -8.85 | 21.49 | -23.47 | -111.48 | -68.37 |
Other Investing Activities | 7.91 | 9.53 | 7.79 | 3.68 | 135.43 | 5.16 |
Investing Cash Flow | 28.25 | -8.99 | 20.57 | -27.15 | 7.65 | -69.26 |
Long-Term Debt Repaid | - | -11.13 | -13.52 | -12.76 | -11.57 | -5.7 |
Total Debt Repaid | -11.13 | -11.13 | -13.52 | -12.76 | -11.57 | -5.7 |
Net Debt Issued (Repaid) | -11.13 | -11.13 | -13.52 | -12.76 | -11.57 | -5.7 |
Other Financing Activities | 3.38 | - | - | - | -0 | - |
Financing Cash Flow | -7.75 | -11.13 | -13.52 | -12.76 | -11.57 | -5.7 |
Foreign Exchange Rate Adjustments | -12.78 | -7.9 | 3.06 | 2.34 | 10.12 | -4.52 |
Net Cash Flow | 89.3 | 87.7 | 61.17 | 50.85 | -23.03 | -68.66 |
Free Cash Flow | 67.26 | 105.84 | 42.2 | 80.53 | -46.72 | 4.6 |
Free Cash Flow Growth | 18.51% | 150.80% | -47.59% | - | - | -93.63% |
Free Cash Flow Margin | 7.30% | 11.34% | 6.13% | 15.21% | -10.08% | 0.87% |
Free Cash Flow Per Share | 0.08 | 0.13 | 0.05 | 0.09 | -0.06 | 0.01 |
Cash Interest Paid | - | - | - | - | 0 | - |
Cash Income Tax Paid | 55.4 | 30.42 | 5.38 | 21.76 | 2.9 | -1.91 |
Levered Free Cash Flow | -37.25 | 76.34 | 21.31 | 80.67 | -28.46 | 51.11 |
Unlevered Free Cash Flow | -36.58 | 76.34 | 21.31 | 80.67 | -28.46 | 51.11 |
Change in Working Capital | -32 | -32 | -38.8 | 27.68 | -57.9 | -19.08 |